Please login to the form below

Not currently logged in
Email:
Password:

Hansa Medical poaches Vifor Pharma’s CEO

Søren Tulstrup becomes the Swedish biopharma’s CEO and president

Soren TulstropHansa Medical has appointed Søren Tulstrup as its new chief executive officer and president, roles that will see him succeed acting CEO Ulf Wiinberg who reverts to his former role as chairman of the Swedish biopharma.

Tulstrup was most recently CEO of Swiss pharmaceutical group Vifor Pharma and prior to this he served as senior vice president, global franchise head at Shire.

Ulf Wiinberg, chairman at Hansa Medical, said: “Søren is an accomplished life science industry executive, who brings diverse and extensive industry experience having built and led high-performance biopharma companies, country operations and teams both in Europe and the US.”

Additionally, Tulstrup has served as CEO of Santaris Pharma, now part of Roche, and in several senior commercial roles within Merck & Co and Sandoz Pharma.

Wiinberg concluded: “Søren’s strong track record of managing the development, launch and growth of biopharmaceuticals globally for the treatment of rare diseases and kidney diseases greatly matches Hansa Medical’s promising position.”

29th March 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics